Roche/taspoglutide - again a PR without material details such as the exact reductions in HbA1C, but those will be presented at ADA. http://www.easybourse.com/bourse/actualite/update-roche-s-experimental-diabetes-drug-meets-study-goals-FR0010259150-797371